Hua-Huy, T.; Günther, S.; Lorut, C.; Subileau, M.; Aubourg, F.; Morbieu, C.; Marey, J.; Texereau, J.; Fajac, I.; Mouthon, L.;
et al. Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia. J. Pers. Med. 2022, 12, 1631.
https://doi.org/10.3390/jpm12101631
AMA Style
Hua-Huy T, Günther S, Lorut C, Subileau M, Aubourg F, Morbieu C, Marey J, Texereau J, Fajac I, Mouthon L,
et al. Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia. Journal of Personalized Medicine. 2022; 12(10):1631.
https://doi.org/10.3390/jpm12101631
Chicago/Turabian Style
Hua-Huy, Thông, Sven Günther, Christine Lorut, Marielle Subileau, Frédérique Aubourg, Caroline Morbieu, Jonathan Marey, Joëlle Texereau, Isabelle Fajac, Luc Mouthon,
and et al. 2022. "Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia" Journal of Personalized Medicine 12, no. 10: 1631.
https://doi.org/10.3390/jpm12101631
APA Style
Hua-Huy, T., Günther, S., Lorut, C., Subileau, M., Aubourg, F., Morbieu, C., Marey, J., Texereau, J., Fajac, I., Mouthon, L., Roche, N., & Dinh-Xuan, A. T.
(2022). Distal Lung Inflammation Assessed by Alveolar Concentration of Nitric Oxide Is an Individualised Biomarker of Severe COVID-19 Pneumonia. Journal of Personalized Medicine, 12(10), 1631.
https://doi.org/10.3390/jpm12101631
